Literature DB >> 20835518

The emerging of the fifth malaria parasite (Plasmodium knowlesi): a public health concern?

Sergio Sabbatani1, Sirio Fiorino, Roberto Manfredi.   

Abstract

After examining the most recent scientific evidences, which assessed the role of some malaria plasmodia that have monkeys as natural reservoirs, the authors focus their attention on Plasmodium knowlesi. The infective foci attributable to this last Plasmodium species have been identified during the last decade in Malaysia, in particular in the states of Sarawak and Sabah (Malaysian Borneo), and in the Pahang region (peninsular Malaysia). The significant relevance of molecular biology assays (polymerase chain reaction, or PCR, performed with specific primers for P. knowlesi), is underlined, since the traditional microscopic examination does not offer distinguishing features, especially when the differential diagnosis with Plasmodium malariae is of concern. Furthermore, Plasmodium knowlesi disease may be responsible of fatal cases, since its clinical presentation and course is more severe compared with those caused by P. malariae, paralleling a more elevated parasitemia. The most effective mosquito vector is represented by Anopheles latens; this mosquito is a parasite of both humans and monkeys. Among primates, the natural hosts are Macaca fascicularis, M. nemestina, M. inus, and Saimiri scirea. When remarking the possible severe evolution of P. knowlesi malaria, we underline the importance of an early recognition and a timely management, especially in patients who have their first onset in Western Hospitals, after journeys in Southeast Asian countries, and eventually participated in trekking excursions in the tropical forest. When malaria-like signs and symptoms are present, a timely diagnosis and treatment become crucial. In the light of its emerging epidemiological features, P. knowlesi may be added to the reknown human malaria parasites, whith includes P. vivax, P. ovale, P. malariae, and P. falciparum, as the fifth potential ethiologic agent of human malaria. Over the next few years, it will be mandatory to support an adequate surveillance and epidemiological network. In parallel with epidemiological and health care policy studies, also an accurate appraisal of the clinical features of P. knowlesi-affected patients will be strongly needed, since some preliminary experiences seem to show an increased disease severity, associated with increased parasitemia, in parallel with the progressive increase of inter-human infectious passages of this emerging Plasmodium.

Entities:  

Mesh:

Year:  2010        PMID: 20835518

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  22 in total

1.  Cytoadherence and severe malaria.

Authors:  Alister G Craig; Mohd Fadzli Mustaffa Khairul; Pradeep R Patil
Journal:  Malays J Med Sci       Date:  2012-04

2.  Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.

Authors:  Thomas Seebeck; Geert Jan Sterk; Hengming Ke
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

Review 3.  Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.

Authors:  Li-Juan Zhou; Jing Xia; Hai-Xia Wei; Xiao-Jun Liu; Hong-Juan Peng
Journal:  Parasitol Res       Date:  2016-12-27       Impact factor: 2.289

4.  Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax.

Authors:  Bo Wang; Feng Lu; Yang Cheng; Jian Li; Daisuke Ito; Jetsumon Sattabongkot; Takafumi Tsuboi; Eun-Taek Han
Journal:  Parasitol Res       Date:  2012-10-25       Impact factor: 2.289

5.  Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons.

Authors:  Rajesh Kumar; Ruth Nyakundi; Thomas Kariuki; Hastings Ozwara; Onkoba Nyamongo; Godfree Mlambo; Barry Ellefsen; Drew Hannaman; Nirbhay Kumar
Journal:  Vaccine       Date:  2013-05-16       Impact factor: 3.641

6.  Protective Effect of Chronic Schistosomiasis in Baboons Coinfected with Schistosoma mansoni and Plasmodium knowlesi.

Authors:  Ruth K Nyakundi; Onkoba Nyamongo; Jeneby Maamun; Mercy Akinyi; Isaac Mulei; Idle O Farah; D'Arbra Blankenship; Brian Grimberg; Jann Hau; Indu Malhotra; Hastings Ozwara; Christopher L King; Thomas M Kariuki
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

7.  Co-incidental Plasmodium Knowlesi and Mucormycosis infections presenting with acute kidney injury and lower gastrointestinal bleeding.

Authors:  Arunachalam Ramaswami; Jayakrishnan K Pisharam; Hla Aung; Kafeel Ghazala; Khalil Maboud; Vui Heng Chong; Jackson Tan
Journal:  Am J Case Rep       Date:  2013-04-10

8.  Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years.

Authors:  W Zheng; H Jiang; Z Xiong; Z Jiang; H Chen
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

9.  Real-time PCR assay for discrimination of Plasmodium ovale curtisi and Plasmodium ovale wallikeri in the Ivory Coast and in the Comoros Islands.

Authors:  Frédérique Bauffe; Jérôme Desplans; Christophe Fraisier; Daniel Parzy
Journal:  Malar J       Date:  2012-09-04       Impact factor: 2.979

10.  Pathogenesis of malaria in tissues and blood.

Authors:  Beatrice Autino; Yolanda Corbett; Francesco Castelli; Donatella Taramelli
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-10-04       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.